Peripheral and Coronary Endothelial Dysfunction In Type 2diabetic Patients- Role of Metformin

NCT00169624 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Coronary and Peripheral Endothelial Dysfunction

Interventions

DRUG: Metformin
DRUG: Gliclazide

Sponsor

Hospices Civils de Lyon